Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Speculation Over Threat To EU’s AI Act Adoption Timelines Looks Unfounded

Executive Summary

EU member states have raised concerns over the EU AI Act. However, opposition is faltering and unlikely to prevent its adoption.

You may also be interested in...

EU Artificial Intelligence Final Text Confirmed By Parliament Committees

The “first AI Act in the world” was adopted with an overwhelming majority by European Parliament Committees IMCO and LIBE.

‘Deep Concerns’ Raised Over EHDS Regulation By Medtech Industry

Health stakeholder organizations including COCIR and MedTech Europe have issued a press statement outlining 10 fundamental issues with the European Health Data Space Regulation. The groups’ areas of focus include: legal clarity and member state harmonization; coordination and cooperation with existing infrastructures and stakeholders; and training.

NICE Recommends Endoscopic Sleeve Gastroplasty To Treat Obesity

NICE has recommended endoscopic sleeve gastroplasty for the treatment of obesity in adults.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts